Nuo Therapeutics Inc
OTC:AURX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nuo Therapeutics Inc
OTC:AURX
|
US |
Profitability Summary
Nuo Therapeutics Inc's profitability score is 24/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
Score
Margins
Earnings Waterfall
Nuo Therapeutics Inc
Margins Comparison
Nuo Therapeutics Inc Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| US |
|
Nuo Therapeutics Inc
OTC:AURX
|
58.5m USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
11.6B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gartner Inc
NYSE:IT
|
11.4B USD |
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
ICON PLC
NASDAQ:ICLR
|
7.6B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cytokinetics Inc
NASDAQ:CYTK
|
7.6B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Charles River Laboratories International Inc
NYSE:CRL
|
7.6B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
7.5B USD |
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
Verona Pharma PLC
NASDAQ:VRNA
|
7.4B USD |
Loading...
|
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Nuo Therapeutics Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
|
Nuo Therapeutics Inc
OTC:AURX
|
58.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
11.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gartner Inc
NYSE:IT
|
11.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
ICON PLC
NASDAQ:ICLR
|
7.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cytokinetics Inc
NASDAQ:CYTK
|
7.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Charles River Laboratories International Inc
NYSE:CRL
|
7.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
7.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
Verona Pharma PLC
NASDAQ:VRNA
|
7.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
